Associated Papers
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.
Enyedi EE et al.
Biomedicines, 2024
Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review.
Yang N et al.
Bmc Pediatrics, 2024
Whole-exome sequencing identified recurrent and novel variants in benzene-induced leukemia.
Lin D et al.
Bmc Medical Genomics, 2023
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine.
Veeravalli S et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2020
Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease.
Phillips IR et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2020
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
Complex patterns of genomic admixture within southern Africa.
Petersen DC et al.
Plos Genetics, 2013
Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.
Krueger SK et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2009
The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa.
Veeramah KR et al.
Pharmacogenetics and Genomics, 2008
Flavin-containing monooxygenases: mutations, disease and drug response.
Phillips IR et al.
Trends in Pharmacological Sciences, 2008
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.
Krueger SK et al.
Pharmacology & Therapeutics, 2005
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.
Krueger SK et al.
Pharmacogenetics and Genomics, 2005
Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.
Krueger SK et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2004
The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development.
Cashman JR
Drug Discovery Today, 2004
Genetic polymorphisms of flavin-containing monooxygenase (FMO).
Krueger SK et al.
Drug Metabolism Reviews, 2002